HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emergency use of extracorporeal membrane oxygenation in cardiopulmonary failure.

Abstract
Severe pulmonary and cardiopulmonary failure resistant to critical care treatment leads to hypoxemia and hypoxia-dependent organ failure. New treatment options for cardiopulmonary failure are necessary even for patients in outlying medical facilities. If these patients are in need of specialized center treatment, additional emergency medical service has to be carried out quick and safely. We describe our experiences with a pumpless extracorporeal lung assist (PECLA/iLA) for out-of-center emergency treatment of hypercapnic respiratory failure and the use of a newly developed hand-held extracorporeal membrane oxygenation (ECMO) system in cardiac, pulmonary, and cardiopulmonary failure (EMERGENCY-LIFE Support System, ELS System, MAQUET Cardiopulmonary AG, Hechingen, Germany). Between March 2000 and April 2009, we used the PECLA System (n = 20) and the ELS System (n = 33) in adult patients. Cannulation was employed using percutaneous vessel access. The new hand-held ELS System consists of a centrifugal pump and a membrane oxygenator, both mounted on a special holder system for storing on a standard patient gurney for air or ground ambulance transfer. Bedside cannulation processes were uneventful. The PECLA System resulted in sufficient CO(2) removal. In all ECMO patients, oxygen delivery and systemic blood flow could be restored and vasopressor support was markedly down. Hospital survival rate in the PECLA group was 50%, and 61% in the ECMO group. Out-of-center emergency treatment of hypercapnic pulmonary failure with pumpless extracorporeal gas exchange and treatment of cardiac, pulmonary, and cardiopulmonary failure with this new hand-held ECMO device is safe and highlyeffective. Patient outcome in cardiopulmonary organ failure could be improved.
AuthorsMatthias Arlt, Alois Philipp, Markus Zimmermann, Sabine Voelkel, Matthias Amann, Thomas Bein, Thomas Müller, Maik Foltan, Christof Schmid, Bernhard Graf, Michael Hilker
JournalArtificial organs (Artif Organs) Vol. 33 Issue 9 Pg. 696-703 (Sep 2009) ISSN: 1525-1594 [Electronic] United States
PMID19775261 (Publication Type: Journal Article)
Chemical References
  • Anticoagulants
Topics
  • Adolescent
  • Adult
  • Aged
  • Anticoagulants (therapeutic use)
  • Cardiopulmonary Resuscitation (adverse effects, instrumentation)
  • Catheterization, Peripheral
  • Critical Illness
  • Emergency Treatment
  • Equipment Design
  • Extracorporeal Membrane Oxygenation (adverse effects, instrumentation)
  • Female
  • Health Services Accessibility
  • Heart Failure (mortality, therapy)
  • Hospital Mortality
  • Humans
  • Hypercapnia (therapy)
  • Length of Stay
  • Male
  • Middle Aged
  • Miniaturization
  • Oxygenators, Membrane
  • Patient Admission
  • Patient Discharge
  • Respiratory Insufficiency (mortality, therapy)
  • Time Factors
  • Transportation of Patients
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: